Educational information

This lecture by prof. Brian Ference was part of an accredited symposium "LDL-c guidance on the novel ESC/EAS dyslipidaemia guidelines: Expert discussions on practical implications" held during ESC 2019 in Paris, France.

Faculty

Prof. Brian A. Ference, M.D, Professor and Director of Research in Translational Therapeutics, Executive Director, Centre for Naturally Randomized Trials, University of Cambridge, United Kingdom

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

Funding

Funding for this educational program was provided by an unrestricted educational grant from Amgen, Sanofi-Regeneron and Pfizer - Upjohn.

Read our summary of the ESC/EAS Dyslipidemia Guidelines View the slides of this presentation